Department of Pharmacology, Urogenix, Inc./Astellas Pharma, Durham, NC 27703, USA.
Department of Pharmacology, Urogenix, Inc./Astellas Pharma, Durham, NC 27703, USA.
Life Sci. 2014 Mar 28;100(1):35-44. doi: 10.1016/j.lfs.2014.01.071. Epub 2014 Feb 2.
Bombesin receptors (BB receptors) and bombesin related peptides are expressed in the lower urinary tract of rodents. Here we investigated whether in vivo activation of BB receptors can contract the urinary bladder and facilitate micturition in sham rats and in a diabetic rat model of voiding dysfunction.
In vivo cystometry experiments were performed in adult female Sprague-Dawley rats under urethane anesthesia. Diabetes was induced by streptozotocin (STZ; 65mg/kg, i.p.) injection. Experiments were performed 9 and 20weeks post STZ-treatment. Drugs included neuromedin B (NMB; BB1 receptor preferring agonist), and gastrin-releasing peptide (GRP; BB2 receptor preferring agonist).
NMB and GRP (0.01-100μg/kg in sham rats; 0.1-300μg/kg in STZ-treated rats, i.v.) increased micturition frequency, bladder contraction amplitude and area under the curve dose dependently in both sham and STZ-treated rats. In addition, NMB (3, 10μg/kg i.v.) triggered voiding in >80% of STZ-treated rats when the bladder was filled to a sub-threshold voiding volume. NMB and GRP increased mean arterial pressure and heart rate at the highest doses, 100 and 300μg/kg.
Activation of bombesin receptors facilitated neurogenic bladder contractions in vivo. Single applications of agonists enhanced or triggered voiding in sham rats as well as in the STZ-treated rat model of diabetic voiding dysfunction. These results suggest that BB receptors may be targeted for drug development for conditions associated with poor detrusor contraction such as an underactive bladder condition.
铃蟾肽受体(BB 受体)和铃蟾肽相关肽在啮齿动物的下尿路中表达。在这里,我们研究了 BB 受体的体内激活是否可以收缩膀胱并促进假手术大鼠和排尿功能障碍的糖尿病大鼠模型中的排尿。
在乌拉坦麻醉下对成年雌性 Sprague-Dawley 大鼠进行体内膀胱测压实验。通过链脲佐菌素(STZ;65mg/kg,腹腔注射)注射诱导糖尿病。实验在 STZ 处理后 9 周和 20 周进行。药物包括神经调节素 B(NMB;BB1 受体优先激动剂)和胃泌素释放肽(GRP;BB2 受体优先激动剂)。
NMB 和 GRP(假手术大鼠中 0.01-100μg/kg;STZ 处理大鼠中 0.1-300μg/kg,静脉注射)剂量依赖性地增加了假手术和 STZ 处理大鼠的排尿频率、膀胱收缩幅度和曲线下面积。此外,当膀胱充满亚阈排尿量时,NMB(3、10μg/kg 静脉注射)引发了>80%的 STZ 处理大鼠的排尿。NMB 和 GRP 在最高剂量 100 和 300μg/kg 时增加平均动脉压和心率。
铃蟾肽受体的激活促进了体内神经源性膀胱收缩。激动剂的单次应用增强或触发了假手术大鼠以及 STZ 处理的糖尿病排尿功能障碍大鼠模型的排尿。这些结果表明,BB 受体可能成为开发与逼尿肌收缩不良相关的疾病(如膀胱活动低下)药物的靶点。